NLS Pharmaceutics AG (NLSPW)
undefined
undefined%
At close: undefined
0.01
0.00%
After-hours Dec 13, 2024, 03:41 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 897.68K 8.95M 5.43M 93.71K 220.27K 6.68K 2.18M
Short-Term Investments - - - - - - -
Long-Term Investments - - - 67.95K 54.47K 55.47K -
Other Long-Term Assets 16.89K 12.14K 12.04K 946.91K 260.21K 1.00 14.37K
Receivables 10.66K - - - 75.39K 36.89K -
Inventory - -41.24K -38.55K -61.21K - -9.36K -
Other Current Assets 914.72K 191.02K 215.87K 14.41K 15.07K 46.59K 2.63K
Total Current Assets 1.82M 9.25M 5.72M 196.71K 381.75K 90.16K 2.27M
Property-Plant & Equipment 6.69K 18.10K 29.51K - - - -
Goodwill & Intangibles - - - - - - -
Total Long-Term Assets 23.58K 30.25K 41.55K 1.01M 314.68K 55.47K 14.37K
Total Assets 1.85M 9.28M 5.76M 1.21M 696.43K 145.63K 2.29M
Account Payables 4.63M 2.37M 1.74M 4.01M 2.51M 1.13M 564.95K
Deferred Revenue - - 2.50B 2.50B -1 - -
Short-Term Debt 1.63M - - 1.77M 690.07K 707.68K -
Other Current Liabilities 1.65M 986.44K 666.45K 1.43M 835.68K 576.31K 425.00K
Total Current Liabilities 7.92M 3.36M 2.40M 7.20M 4.04M 2.41M 989.96K
Long-Term Debt - - - 313.48K 152.06K 6.39M 8.87M
Other Long-Term Liabilities 260.69K 136.12K 318.89K 178.27K 180.25K 159.02K 148.25K
Total Long-Term Liabilities 2.76M 2.64M 2.82M 2.99M 2.83M 6.54M 9.02M
Total Liabilities 10.68M 6.00M 5.22M 10.20M 6.87M 8.96M 10.01M
Total Debt 1.63M - - 2.08M 842.13K 7.09M 8.87M
Common Stock 733.41K 668.55K 344.44K 145.14K 145.14K 133.54K 128.34K
Retained Earnings -70.37M -58.20M -41.71M -29.76M -26.90M -21.45M -16.30M
Comprehensive Income -158.07K -50.79K -151.74K -19.38K -18.70K -11.25K -9.99K
Shareholders Equity -8.83M 3.28M 542.39K -8.98M -6.17M -8.81M -7.72M
Total Investments - - - 67.95K 54.47K 55.47K -